Biocartis Group €115 million IPO on Euronext Brussels

Overview:

• The Biocartis Group has undertaken a €115 million IPO, listed on Euronext Brussels.
• KBC Securities acted as global coordinator and joint bookrunner on the issue, with Petercam, and Kempen & Co also serving as joint bookrunners.
• Biocartis is a Belgium-based molecular diagnostics company that develops clinical tests in the oncology and infectious diseases sectors.

Kurt Stumpo - Journalist